UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

Leukemia, 2017-07, Vol.31 (7), p.1622-1625

2017

Volltextzugriff (PDF)

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

Oncogene, 2016-08, Vol.35 (33), p.4422-4422

2016

Volltextzugriff (PDF)

PP 78 Role of mucin3 gene in intrinsic resistance to oxaliplatin

European journal of cancer (1990), 2011, Vol.47, p.S23-S23

2011

Volltextzugriff (PDF)

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

Oncogene, 2016-08, Vol.35 (33), p.4407-4413

2016

Volltextzugriff (PDF)

P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S235

2023

Volltextzugriff (PDF)

1001 CDK5 is Involved in Oxaliplatin Response and Resistance Acquisition Through Regulation of STAT3 Transcription Factor

European journal of cancer (1990), 2012-07, Vol.48, p.S242-S242

2012

Volltextzugriff (PDF)

Occult triple negative male breast cancer. The usefulness of molecular platforms. A case report

Current problems in cancer. Case reports, 2021-12, Vol.4, p.100097, Article 100097

2021

Volltextzugriff (PDF)

Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Oncogene, 2017-07, Vol.36 (29), p.4233-4233

2017

Volltextzugriff (PDF)

Erratum: Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

Oncogene, 2016-08, Vol.35 (33), p.4422-4422

2016

Volltextzugriff (PDF)

Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells

International journal of oncology, 2006-07, Vol.29 (1), p.225-235

2006

Volltextzugriff (PDF)

Prédiction épigénétique du bénéfice clinique avec les anti-PD-1 dans le traitement des cancers du poumon non à petites cellules avancées : une étude internationale multicentrique rétrospective

Revue des maladies respiratoires, 2019-01, Vol.36, p.A40-A41

2019

Volltextzugriff (PDF)

141P Unveiling the likely pharmacological mechanisms of brigatinib on brain metastasis in ALK+ patients with non-small cell lung cancer: A systems biology and artificial intelligence-based approach

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S119

2023

Volltextzugriff (PDF)

120P Prognostic significance of SAMHD1 expression in breast cancer

Annals of oncology, 2021-05, Vol.32, p.S73

2021

Volltextzugriff (PDF)

291P Prognosis of glioblastoma according to different TERT promoter mutations

Annals of oncology, 2022-09, Vol.33, p.S672

2022

Volltextzugriff (PDF)

9MO Profile of immunorecognition related markers including HLA-1 expression to predict response to immunocheckpoint inhibitors in non-small cell lung cancer

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S42

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONGITUDINAL PREVALENCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN BREAST AND OVARIAN CANCER PATIENTS PRIOR AND AFTER RECEIVING CYTOTOXIC TREATMENT

Leukemia research, 2023-05, Vol.128, p.107175, Article 107175

2023

Volltextzugriff (PDF)

33P Epigenetic biomarkers ID1, HOXB2 and ATOH8 could predict response to chemotherapy and prognosis in early breast cancer

Annals of oncology, 2021-05, Vol.32, p.S34

2021

Volltextzugriff (PDF)

Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma

EJC skin cancer, 2024, Vol.2, p.100161, Article 100161

2024

Volltextzugriff (PDF)

A-397 - Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma

EJC skin cancer, 2024, Vol.2

2024

Volltextzugriff (PDF)

3011 ORAL Role of Thymidylate synthase –6bp/1494 deletion polymorphism in capecitabine or 5-fluorouracil (5FU) selection in first line oxaliplatin-based chemotherapy in advanced colorectal cancer

European journal of cancer supplements, 2007, Vol.5 (4), p.238-238

2007

Volltextzugriff (PDF)

Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4066-4066

2009

Volltextzugriff (PDF)

In vitro-acquired resistance gene expression profile and in vivo response to oxaliplatin-based treatment

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15041-e15041

2009

Volltextzugriff (PDF)

Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

Nature reviews. Clinical oncology, 2017-11, Vol.14 (11), p.682-694

2017

Volltextzugriff (PDF)

6121 Gene expression profile related to oxaliplatin (OXA) intrinsic resistance in a panel of 14 human colorectal cancer (CRC) cell lines

European journal of cancer supplements, 2009, Vol.7 (2), p.359-359

2009

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(89)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

PP 78 Role of mucin3 gene in intrinsic resistance to oxaliplatin

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy

1001 CDK5 is Involved in Oxaliplatin Response and Resistance Acquisition Through Regulation of STAT3 Transcription Factor

Occult triple negative male breast cancer. The usefulness of molecular platforms. A case report

Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Erratum: Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis

Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells

Prédiction épigénétique du bénéfice clinique avec les anti-PD-1 dans le traitement des cancers du poumon non à petites cellules avancées : une étude internationale multicentrique rétrospective

141P Unveiling the likely pharmacological mechanisms of brigatinib on brain metastasis in ALK+ patients with non-small cell lung cancer: A systems biology and artificial intelligence-based approach

120P Prognostic significance of SAMHD1 expression in breast cancer

291P Prognosis of glioblastoma according to different TERT promoter mutations

9MO Profile of immunorecognition related markers including HLA-1 expression to predict response to immunocheckpoint inhibitors in non-small cell lung cancer

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONGITUDINAL PREVALENCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN BREAST AND OVARIAN CANCER PATIENTS PRIOR AND AFTER RECEIVING CYTOTOXIC TREATMENT

33P Epigenetic biomarkers ID1, HOXB2 and ATOH8 could predict response to chemotherapy and prognosis in early breast cancer

Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma

A-397 - Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma

3011 ORAL Role of Thymidylate synthase –6bp/1494 deletion polymorphism in capecitabine or 5-fluorouracil (5FU) selection in first line oxaliplatin-based chemotherapy in advanced colorectal cancer

965P Role of STAT3 (signal transducer and activator of transcription 3) activation and its regulation by PTPRT (protein receptor tyrosine phosphatase type T) and response to paclitaxel and cetuximab in patients (P) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil

In vitro-acquired resistance gene expression profile and in vivo response to oxaliplatin-based treatment

Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

6121 Gene expression profile related to oxaliplatin (OXA) intrinsic resistance in a panel of 14 human colorectal cancer (CRC) cell lines

Aktive Filter

Suchergebnisse filtern